1-3 of about 3 matches for site:www.fool.com tirzepatide
https://www.fool.com/investing/2026/07/09/record-numbers-of-americans-...
But Lilly has to be considered the biggest beneficiary, as its drug tirzepatide, marketed as Mounjaro for
https://www.fool.com/investing/2026/07/13/heres-how-much-eli-lillys-we...
many investors realize. Image source: Getty Images. A franchise still accelerating Mounjaro, Lilly's tirzepatide-based treatment for
https://www.fool.com/investing/2026/07/14/is-this-disturbing-trend-bad...
and Wegovy, for type 2 diabetes and weight loss, respectively. Lilly sells tirzepatide as Mounjaro for